[BIOS] BioScrip, Inc.

Overview

Type of security: Stock

Sector: Health Care

Industry: Medical/Nursing Services

Market Capitalization:

Exchange: NASDAQ

The data is delayed by 15 minutes.

 

Price: 1.03 Change: 0.01 (0.98%)
Ext. hours: Change: 0 (0%)

chart BIOS

Refresh chart

Description: BioScrip, Inc. provides home infusion and other home care services, and pharmacy benefit management (PBM) services in the United States. It operates in three segments: Infusion Services, Home Health Services, and PBM Services. The Infusion Services segment offers home infusion and respiratory therapy services; and durable medical equipment, products, and services. Its home infusion services include the intravenous administration of medications to treat various acute and chronic conditions, such as infections, nutritional deficiencies, immunologic and neurologic conditions, cancer, pain, and palliative care. This segment offers services, including the dispensing and administering of infusion-based drugs, which require nursing support and clinical management services; equipment to administer the dosage; and patient training. The Home Health Services segment provides skilled nursing, wound care, oncology nursing and infusion nursing, medical social services, home health aide services, private duty nursing care,

Fundamental Ratios
Shares Outstanding EPS-0.42 EPS Growth - 4 Quarters EPS Growth - Q/Q
EPS Growth - Y/Y Sales Growth - 4 Quarters 5.89% Sales Growth - Q/Q3.15% P/E-6.02
P/E To EPS Growth P/S P/BV Price/Cash Per Share
Price/Free Cash Flow ROA-16.78% ROE-54.92% ROI-22.68%
Current Ratio1.46 Quick Ratio1.17 Long Term Debt/Equity6.23 Debt Ratio0.56
Gross Margin26.08% Operating Margin-8.41% Net Profit Margin-14.09% Dividend Payout Ratio
Dividend Yield
Fundamental Data
Cash From Financing Activities52.62 M Cash From Investing Activities-2.07 M Cash From Operating Activities-28.05 M Gross Profit66.47 M
Net Profit-19.67 M Operating Profit-4.81 M Total Assets845.42 M Total Current Assets212.35 M
Total Current Liabilities145.16 M Total Debt418.83 M Total Liabilities587.2 M Total Revenue261.68 M
Technical Data
High 52 week4 Low 52 week1.61 Last close2.11 Last change2.43%
RSI62.5 Average true range0.11 Beta0.74 Volume903.26 K
Simple moving average 20 days7.71% Simple moving average 50 days0.08% Simple moving average 200 days-24.71%
Performance Data
Performance Week5.5% Performance Month22.67% Performance Quart-41.55% Performance Half-29.43%
Performance Year-22.14% Performance Year-to-date-45.48% Volatility daily3.95% Volatility weekly8.84%
Volatility monthly18.11% Volatility yearly62.72% Relative Volume179.15% Average Volume1.66 M
New High New Low

News

2020-05-07 17:49:08 | Edited Transcript of BIOS earnings conference call or presentation 7-May-20 12:30pm GMT

2020-03-29 19:02:27 | Is BioScrip Inc. BIOS Relatively A Good Stock To Buy?

2020-03-25 14:45:27 | Edited Transcript of BIOS earnings conference call or presentation 5-Mar-20 1:30pm GMT

2020-03-05 16:02:39 | BioScrip, Inc. -- Moody's announces completion of a periodic review of ratings of Option Care Health, Inc.

2020-02-03 08:30:10 | Option Care Health Completes Reverse Stock Split and Ticker Symbol Change

2019-12-26 16:24:01 | RLH Corporation Appoints R. Carter Pate as Chairman

2019-12-23 14:57:06 | Option Care Health, Inc. BIOS: Are Hedge Funds Right About This Stock?

2019-12-18 09:22:56 | Option Care Health to Participate in the 38th Annual J.P. Morgan Healthcare Conference

2019-12-06 11:31:04 | Option Care BIOS Down 12% Since Last Earnings Report: Can It Rebound?

2019-12-05 08:51:01 | Option Care Health BIOS Surges: Stock Moves 7.3% Higher

2019-12-02 08:00:10 | Daniel E. Greenleaf Appointed as Chief Executive Officer of The Providence Service Corporation and LogistiCare

2019-11-21 10:39:29 | Option Care Health to Participate in the Bank of America Merrill Lynch 2019 Leveraged Finance Conference

2019-11-20 09:36:02 | Option Care is the Preferred Provider of Haemophilia Treatment

2019-11-19 14:14:29 | Option Care Health Selected by Highmark as Preferred Provider of Hemophilia Treatment

2019-11-11 07:50:49 | Is Option Care Health NASDAQ:BIOS Using Too Much Debt?

2019-11-08 07:53:25 | Edited Transcript of BIOS earnings conference call or presentation 6-Nov-19 1:30pm GMT

2019-11-07 11:18:04 | Option Care Health BIOS Q3 Earnings Meet, Revenues Top

2019-11-06 14:46:42 | Is Option Care Health, Inc. BIOS A Good Stock To Buy?

2019-11-06 10:25:03 | Option Care BIOS Reports Q3 Loss, Tops Revenue Estimates

2019-11-06 06:00:00 | Option Care Health Announces Third Quarter Results

2019-10-30 10:34:02 | Option Care BIOS May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

2019-10-16 16:05:00 | Option Care Health to Announce Third Quarter 2019 Financial Results and Host Conference Call

2019-10-01 15:06:07 | Learn How to Find Top-Ranked 'Cheap' Stocks Under $10 with this Screener

2019-09-17 10:00:02 | Here's Why Momentum Investors Will Love BioScrip BIOS

2019-09-16 08:38:12 | Moving Average Crossover Alert: Option Care Health

2019-09-12 10:02:02 | Top Ranked Momentum Stocks to Buy for September 12th

2019-08-29 18:05:00 | Option Care Health to Participate in the Morgan Stanley 17th Annual Global Healthcare Conference

2019-08-27 16:01:00 | Kathryn Stalmack appointed as SVP, General Counsel and Corporate Secretary of Providence Service Corporation and LogistiCare

2019-08-16 08:26:49 | Why Denver-based Bioscrip decided to merge with a competitor

2019-08-13 17:00:00 | Option Care Health Receives Anticipated Nasdaq Notice

2019-08-08 10:03:02 | BioScrip Closes Option Care Merger, Incurs Wider Q2 Loss

2019-08-07 08:00:00 | Option Care and BioScrip Complete Merger to Form Option Care Health

2019-08-02 12:40:00 | BioScrip Announces Shareholder Approval of Merger with Option Care

2019-07-30 09:45:01 | BioScrip BIOS Reports Q2 Loss, Tops Revenue Estimates

2019-07-30 08:00:00 | BioScrip Reports Second Quarter 2019 Financial Results

2019-07-22 09:00:00 | Leading Independent Proxy Advisory Firms, ISS and Glass Lewis, Recommend that BioScrip Stockholders Vote “FOR” the Transaction Proposals in Connection with the Proposed Merger with Option Care

2019-07-05 12:29:30 | Is BioScrip Inc. BIOS A Good Stock To Buy?

2019-07-02 09:14:01 | BioScrip, Inc. BIOS Shares March Higher, Can It Continue?

2019-06-26 11:24:50 | BIOS, CRAY, ZAYO SHAREHOLDER LEGAL UPDATE: Halper Sadeh LLP Announces Shareholder Class Actions Against the Following Companies – BIOS, CRAY, ZAYO

2019-06-24 09:29:00 | LogistiCare Announces Leadership Transition

2019-06-21 20:00:00 | URGENT ALERT: Monteverde & Associates PC Launches an Investigation Regarding the Following Merger

2019-06-18 06:14:10 | BioScrip, Inc.'s Shares March Higher, Can It Continue?

2019-06-13 09:00:00 | Key Members of BioScrip’s Leadership Team to Continue in Executive Roles with Combined Company Following Close of Option Care Merger

2019-06-10 11:47:37 | RLH Corporation Announces Changes to Its Board of Directors

2019-06-01 09:31:01 | BioScrip BIOS Up 5.2% Since Last Earnings Report: Can It Continue?

2019-05-21 09:00:00 | BioScrip to Participate in Upcoming Investor Conferences

2019-05-14 20:08:11 | BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable

2019-05-09 20:59:39 | Here’s What Hedge Funds Think About BioScrip Inc. BIOS

2019-05-09 10:36:02 | BioScrip's Option Care Merger on Track, Q1 Loss Narrows

2019-05-03 11:00:00 | MERGER INVESTIGATION NOTICE: Kaskela Law LLC Announces Shareholder Investigation of BioScrip, Inc. – BIOS